Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HN.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
BA.5.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
MK.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
A.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
XBB.1.5.39SWon-SCTACATGCACCAGCAACTGT20502311423133F-20413.7South Korea
BN.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-20407.1China
AY.4.16 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-20407.1China
AY.4.16 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-20394.2Germany
BN.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-20394.2Germany
KP.4.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-20389.3US
JN.1.42.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-20387.2Germany
BN.1.1.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-20385.1US
B.1.177.42NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-20376.5Thailand
HW.1.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-20362.3US
BR.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20351.8US
B.1.441NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-20347.6China
XBB.1.5.109SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20346.1Japan
JN.1.35SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-20341.7Singapore
HK.3.10SWon-SCTACATGCACCAGCAACTGT20502311423133F-20338.9South Korea
JN.1.39.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-20338.9South Korea
XBB.1.18.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-20338.9South Korea
FY.9SWon-SCTACATGCACCAGCAACTGT20502311423133F-20338.9South Korea
BA.4.1.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-20338.9South Korea
KP.2.14SWon-SCTACATGCACCAGCAACTGT20502311423133F-20338.9South Korea
B.1.438.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-20338.9South Korea
B.1.1.273SWon-SCTACATGCACCAGCAACTGT20502311423133F-20338.9South Korea
CM.8.1.5NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-20331.1US
XBB.1.16.6NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-20331.1US
B.1.397NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-20331.1US
BF.32NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-20331.1US
B.1.1.517NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-20331.1US
FK.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-20331.1US
CH.1.1.18NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-20331.1US
B.1.1.228NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-20331.1US
B.1.1.174NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-20331.1US
B.4.8NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20326.9US
B.4NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20326.9US
B.4.7NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20326.9US
B.4.4NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20326.9US
B.4.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20326.9US
B.4.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20326.9US
B.1.1.299SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-20316.5South Korea
R.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-20316.5South Korea
AY.130SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-20311.7China
B.1.36.23NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-20306.8China
B.1.1.213ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
B.1.1.12ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
B.1.1.341ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
B.1.1.89ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
B.1.36.23ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used